Skip to main content

Advertisement

Log in

Low Bone Mineral Density in Anorexia Nervosa: Treatments and Challenges

  • Treating Bone Loss in Challenging Situations
  • Published:
Clinical Reviews in Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

Anorexia nervosa, a psychiatric disease predominantly affecting women, is characterized by self-induced starvation and a resultant low-weight state. During starvation, a number of hormonal adaptations—including hypothalamic amenorrhea and growth hormone resistance—allow for decreased energy expenditure during periods of decreased nutrient intake, but these very same adaptations also contribute to the medical complications associated with chronic starvation, including low bone mass. Almost 90% of women with anorexia nervosa have bone mineral density (BMD) values more than one-standard deviation below the mean of healthy women at peak bone mineral density, and this disease is associated with a significantly increased risk of fracture. Although multiple therapies have been studied for the treatment of low bone mass in anorexia nervosa, there are currently no approved therapies and few promising long-term therapeutic options. This review will outline the mediators of low bone mass in anorexia nervosa, discuss therapies that have been studied for the treatment of low BMD in this disorder, and highlight the important challenges that remain, including the differences in bone modeling in adolescents with anorexia nervosa as compared to adults, necessitating that potential therapies be tested in these two populations separately, and the paucity of long-term therapeutic strategies for treating bone loss in this disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lucas AR, Crowson CS, O'Fallon WM, Melton LJ 3rd. The ups and downs of anorexia nervosa. Int J Eat Disord. 1999;26(4):397–405.

    Article  CAS  PubMed  Google Scholar 

  2. Keski-Rahkonen A, Hoek HW, Susser ES, Linna MS, Sihvola E, Raevuori A, et al. Epidemiology and course of anorexia nervosa in the community. Am J Psychiatry. 2007;164(8):1259–65. https://doi.org/10.1176/appi.ajp.2007.06081388.

    Article  PubMed  Google Scholar 

  3. Lowe B, Zipfel S, Buchholz C, Dupont Y, Reas DL, Herzog W. Long-term outcome of anorexia nervosa in a prospective 21-year follow-up study. Psychol Med. 2001;31(5):881–90.

    Article  CAS  PubMed  Google Scholar 

  4. Eddy KT, Tabri N, Thomas JJ, Murray HB, Keshaviah A, Hastings E, et al. Recovery from anorexia nervosa and bulimia nervosa at 22-year follow-up. J Clin Psychiatry. 2017;78(2):184–9. https://doi.org/10.4088/JCP.15m10393.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Miller KK, Grinspoon SK, Ciampa J, Hier J, Herzog D, Klibanski A. Medical findings in outpatients with anorexia nervosa. Arch Intern Med. 2005;165(5):561–6. https://doi.org/10.1001/archinte.165.5.561.

    Article  PubMed  Google Scholar 

  6. Grinspoon S, Thomas E, Pitts S, Gross E, Mickley D, Miller K, et al. Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med. 2000;133(10):790–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Rigotti NA, Neer RM, Skates SJ, Herzog DB, Nussbaum SR. The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass. JAMA. 1991;265(9):1133–8.

    Article  CAS  PubMed  Google Scholar 

  8. Vestergaard P, Emborg C, Stoving RK, Hagen C, Mosekilde L, Brixen K. Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders—a nationwide register study. Int J Eat Disord. 2002;32(3):301–8. https://doi.org/10.1002/eat.10101.

    Article  PubMed  Google Scholar 

  9. Faje AT, Fazeli PK, Miller KK, Katzman DK, Ebrahimi S, Lee H, et al. Fracture risk and areal bone mineral density in adolescent females with anorexia nervosa. Int J Eat Disord. 2014;47(5):458–66. https://doi.org/10.1002/eat.22248.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Nagata JM, Golden NH, Leonard MB, Copelovitch L, Denburg MR. Assessment of sex differences in fracture risk among patients with anorexia nervosa: a population-based cohort study using the health improvement network. J Bone Miner Res Off J Am Soc Bone Miner Res. 2017;32(5):1082–9. https://doi.org/10.1002/jbmr.3068.

    Article  CAS  Google Scholar 

  11. Lucas AR, Melton LJ 3rd, Crowson CS, O'Fallon WM. Long-term fracture risk among women with anorexia nervosa: a population-based cohort study. Mayo Clin Proc. 1999;74(10):972–7. https://doi.org/10.4065/74.10.972.

    Article  CAS  PubMed  Google Scholar 

  12. Grinspoon S, Thomas L, Miller K, Pitts S, Herzog D, Klibanski A. Changes in regional fat redistribution and the effects of estrogen during spontaneous weight gain in women with anorexia nervosa. Am J Clin Nutr. 2001;73(5):865–9. https://doi.org/10.1093/ajcn/73.5.865.

    Article  CAS  PubMed  Google Scholar 

  13. Mayer L, Walsh BT, Pierson RN Jr, Heymsfield SB, Gallagher D, Wang J, et al. Body fat redistribution after weight gain in women with anorexia nervosa. Am J Clin Nutr. 2005;81(6):1286–91. https://doi.org/10.1093/ajcn/81.6.1286.

    Article  CAS  PubMed  Google Scholar 

  14. Kooh SW, Noriega E, Leslie K, Muller C, Harrison JE. Bone mass and soft tissue composition in adolescents with anorexia nervosa. Bone. 1996;19(2):181–8.

    Article  CAS  PubMed  Google Scholar 

  15. Grinspoon S, Miller K, Coyle C, Krempin J, Armstrong C, Pitts S, et al. Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. J Clin Endocrinol Metab. 1999;84(6):2049–55. https://doi.org/10.1210/jcem.84.6.5792.

    Article  CAS  PubMed  Google Scholar 

  16. Turner JM, Bulsara MK, McDermott BM, Byrne GC, Prince RL, Forbes DA. Predictors of low bone density in young adolescent females with anorexia nervosa and other dieting disorders. Int J Eat Disord. 2001;30(3):245–51.

    Article  CAS  PubMed  Google Scholar 

  17. DiVasta AD, Beck TJ, Petit MA, Feldman HA, LeBoff MS, Gordon CM. Bone cross-sectional geometry in adolescents and young women with anorexia nervosa: a hip structural analysis study. Osteoporos Int. 2007;18(6):797–804. https://doi.org/10.1007/s00198-006-0308-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Soyka LA, Misra M, Frenchman A, Miller KK, Grinspoon S, Schoenfeld DA, et al. Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab. 2002;87(9):4177–85. https://doi.org/10.1210/jc.2001-011889.

    Article  CAS  PubMed  Google Scholar 

  19. Miller KK, Lee EE, Lawson EA, Misra M, Minihan J, Grinspoon SK, et al. Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metab. 2006;91(8):2931–7. https://doi.org/10.1210/jc.2005-2818.

    Article  CAS  PubMed  Google Scholar 

  20. Rigotti NA, Nussbaum SR, Herzog DB, Neer RM. Osteoporosis in women with anorexia nervosa. N Engl J Med. 1984;311(25):1601–6. https://doi.org/10.1056/NEJM198412203112503.

    Article  CAS  PubMed  Google Scholar 

  21. Seeman E, Szmukler GI, Formica C, Tsalamandris C, Mestrovic R. Osteoporosis in anorexia nervosa: the influence of peak bone density, bone loss, oral contraceptive use, and exercise. J Bone Miner Res Off J Am Soc Bone Miner Res. 1992;7(12):1467–74. https://doi.org/10.1002/jbmr.5650071215.

    Article  CAS  Google Scholar 

  22. Gordon CM, Goodman E, Emans SJ, Grace E, Becker KA, Rosen CJ, et al. Physiologic regulators of bone turnover in young women with anorexia nervosa. J Pediatr. 2002;141(1):64–70. https://doi.org/10.1067/mpd.2002.125003.

    Article  CAS  PubMed  Google Scholar 

  23. DiVasta AD, Feldman HA, O'Donnell JM, Long J, Leonard MB, Gordon CM. Effect of exercise and antidepressants on skeletal outcomes in adolescent girls with anorexia nervosa. J Adolesc Health. 2017;60(2):229–32. https://doi.org/10.1016/j.jadohealth.2016.10.003.

    Article  PubMed  Google Scholar 

  24. Nagata JM, Carlson JL, Golden NH, Murray SB, Long J, Leonard MB, et al. Associations between exercise, bone mineral density, and body composition in adolescents with anorexia nervosa. Eat Weight Disord. 2018. https://doi.org/10.1007/s40519-018-0521-2.

  25. Biller BM, Saxe V, Herzog DB, Rosenthal DI, Holzman S, Klibanski A. Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J Clin Endocrinol Metab. 1989;68(3):548–54. https://doi.org/10.1210/jcem-68-3-548.

    Article  CAS  PubMed  Google Scholar 

  26. Bachrach LK, Guido D, Katzman D, Litt IF, Marcus R. Decreased bone density in adolescent girls with anorexia nervosa. Pediatrics. 1990;86(3):440–7.

    CAS  PubMed  Google Scholar 

  27. Soyka LA, Grinspoon S, Levitsky LL, Herzog DB, Klibanski A. The effects of anorexia nervosa on bone metabolism in female adolescents. J Clin Endocrinol Metab. 1999;84(12):4489–96. https://doi.org/10.1210/jcem.84.12.6207.

    Article  CAS  PubMed  Google Scholar 

  28. Joyce JM, Warren DL, Humphries LL, Smith AJ, Coon JS. Osteoporosis in women with eating disorders: comparison of physical parameters, exercise, and menstrual status with SPA and DPA evaluation. J Nucl Med. 1990;31(3):325–31.

    CAS  PubMed  Google Scholar 

  29. Frisch RE, Gotz-Welbergen AV, McArthur JW, Albright T, Witschi J, Bullen B, et al. Delayed menarche and amenorrhea of college athletes in relation to age of onset of training. JAMA. 1981;246(14):1559–63.

    Article  CAS  PubMed  Google Scholar 

  30. Grinspoon S, Gulick T, Askari H, Landt M, Lee K, Anderson E, et al. Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab. 1996;81(11):3861–3.

    CAS  PubMed  Google Scholar 

  31. Misra M, Miller KK, Kuo K, Griffin K, Stewart V, Hunter E, et al. Secretory dynamics of leptin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab. 2005;289(3):E373–81. https://doi.org/10.1152/ajpendo.00041.2005.

    Article  CAS  PubMed  Google Scholar 

  32. Chou SH, Chamberland JP, Liu X, Matarese G, Gao C, Stefanakis R, et al. Leptin is an effective treatment for hypothalamic amenorrhea. Proc Natl Acad Sci U S A. 2011;108(16):6585–90. https://doi.org/10.1073/pnas.1015674108.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Welt CK, Chan JL, Bullen J, Murphy R, Smith P, DePaoli AM, et al. Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med. 2004;351(10):987–97. https://doi.org/10.1056/NEJMoa040388.

    Article  CAS  PubMed  Google Scholar 

  34. Fazeli PK, Bredella MA, Misra M, Meenaghan E, Rosen CJ, Clemmons DR, et al. Preadipocyte factor-1 is associated with marrow adiposity and bone mineral density in women with anorexia nervosa. J Clin Endocrinol Metab. 2010;95(1):407–13. https://doi.org/10.1210/jc.2009-1152.

    Article  CAS  PubMed  Google Scholar 

  35. Legroux-Gerot I, Vignau J, Biver E, Pigny P, Collier F, Marchandise X, et al. Anorexia nervosa, osteoporosis and circulating leptin: the missing link. Osteoporos Int. 2010;21(10):1715–22. https://doi.org/10.1007/s00198-009-1120-x.

    Article  CAS  PubMed  Google Scholar 

  36. Bredella MA, Fazeli PK, Miller KK, Misra M, Torriani M, Thomas BJ, et al. Increased bone marrow fat in anorexia nervosa. J Clin Endocrinol Metab. 2009;94(6):2129–36. https://doi.org/10.1210/jc.2008-2532.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Ecklund K, Vajapeyam S, Feldman HA, Buzney CD, Mulkern RV, Kleinman PK, et al. Bone marrow changes in adolescent girls with anorexia nervosa. J Bone Miner Res Off J Am Soc Bone Miner Res. 2010;25(2):298–304. https://doi.org/10.1359/jbmr.090805.

    Article  Google Scholar 

  38. Fazeli PK, Bredella MA, Freedman L, Thomas BJ, Breggia A, Meenaghan E, et al. Marrow fat and preadipocyte factor-1 levels decrease with recovery in women with anorexia nervosa. J Bone Miner Res Off J Am Soc Bone Miner Res. 2012;27(9):1864–71. https://doi.org/10.1002/jbmr.1640.

    Article  CAS  Google Scholar 

  39. Fazeli PK, Faje A, Bredella MA, Polineni S, Russell S, Resulaj M, et al. Changes in marrow adipose tissue with short-term changes in weight in premenopausal women with anorexia nervosa. Eur J Endocrinol. 2018. https://doi.org/10.1530/EJE-18-0824.

  40. Schellinger D, Lin CS, Hatipoglu HG, Fertikh D. Potential value of vertebral proton MR spectroscopy in determining bone weakness. AJNR Am J Neuroradiol. 2001;22(8):1620–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Singhal V, Tulsiani S, Campoverde KJ, Mitchell DM, Slattery M, Schorr M, et al. Impaired bone strength estimates at the distal tibia and its determinants in adolescents with anorexia nervosa. Bone. 2018;106:61–8. https://doi.org/10.1016/j.bone.2017.07.009.

    Article  PubMed  Google Scholar 

  42. Misra M, Tsai P, Anderson EJ, Hubbard JL, Gallagher K, Soyka LA, et al. Nutrient intake in community-dwelling adolescent girls with anorexia nervosa and in healthy adolescents. Am J Clin Nutr. 2006;84(4):698–706.

    Article  CAS  PubMed  Google Scholar 

  43. Haagensen AL, Feldman HA, Ringelheim J, Gordon CM. Low prevalence of vitamin D deficiency among adolescents with anorexia nervosa. Osteoporosis International. 2008;19(3):289–94. https://doi.org/10.1007/s00198-007-0476-z.

    Article  CAS  PubMed  Google Scholar 

  44. Garn SM, Rohmann CG, Behar M, Viteri F, Guzman MA. Compact bone deficiency in protein-calorie malnutrition. Science. 1964;145(3639):1444–5.

    Article  CAS  PubMed  Google Scholar 

  45. Fontana L, Shew JL, Holloszy JO, Villareal DT. Low bone mass in subjects on a long-term raw vegetarian diet. Arch Intern Med. 2005;165(6):684–9. https://doi.org/10.1001/archinte.165.6.684.

    Article  PubMed  Google Scholar 

  46. Fernstrom MH, Weltzin TE, Neuberger S, Srinivasagam N, Kaye WH. Twenty-four-hour food intake in patients with anorexia nervosa and in healthy control subjects. Biol Psychiatry. 1994;36(10):696–702.

    Article  CAS  PubMed  Google Scholar 

  47. Misra M, Miller KK, Tsai P, Gallagher K, Lin A, Lee N, et al. Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab. 2006;91(3):1027–33. https://doi.org/10.1210/jc.2005-1878.

    Article  CAS  PubMed  Google Scholar 

  48. Gatti D, El Ghoch M, Viapiana O, Ruocco A, Chignola E, Rossini M, et al. Strong relationship between vitamin D status and bone mineral density in anorexia nervosa. Bone. 2015;78:212–5. https://doi.org/10.1016/j.bone.2015.05.014.

    Article  CAS  PubMed  Google Scholar 

  49. Mehler PS, Blalock DV, Walden K, Kaur S, McBride J, Walsh K, et al. Medical findings in 1,026 consecutive adult inpatient-residential eating disordered patients. Int J Eat Disord. 2018;51(4):305–13. https://doi.org/10.1002/eat.22830.

    Article  PubMed  Google Scholar 

  50. Verbalis JG, Barsony J, Sugimura Y, Tian Y, Adams DJ, Carter EA, et al. Hyponatremia-induced osteoporosis. J Bone Miner Res Off J Am Soc Bone Miner Res. 2010;25(3):554–63. https://doi.org/10.1359/jbmr.090827.

    Article  CAS  Google Scholar 

  51. Kinsella S, Moran S, Sullivan MO, Molloy MG, Eustace JA. Hyponatremia independent of osteoporosis is associated with fracture occurrence. Clin J Am Soc Nephrol. 2010;5(2):275–80. https://doi.org/10.2215/CJN.06120809.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Jamal SA, Arampatzis S, Harrison SL, Bucur RC, Ensrud K, Orwoll ES, et al. Hyponatremia and fractures: findings from the MrOS study. J Bone Miner Res Off J Am Soc Bone Miner Res. 2015;30(6):970–5. https://doi.org/10.1002/jbmr.2383.

    Article  CAS  Google Scholar 

  53. Lawson EA, Fazeli PK, Calder G, Putnam H, Misra M, Meenaghan E, et al. Plasma sodium level is associated with bone loss severity in women with anorexia nervosa: a cross-sectional study. J Clin Psychiatry. 2012;73(11):e1379–83. https://doi.org/10.4088/JCP.12m07919.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5). 5th ed. Washington, DC; 2013.

  55. Miller KK, Lawson EA, Mathur V, Wexler TL, Meenaghan E, Misra M, et al. Androgens in women with anorexia nervosa and normal-weight women with hypothalamic amenorrhea. J Clin Endocrinol Metab. 2007;92(4):1334–9. https://doi.org/10.1210/jc.2006-2501.

    Article  CAS  PubMed  Google Scholar 

  56. Lawson EA, Miller KK, Bredella MA, Phan C, Misra M, Meenaghan E, et al. Hormone predictors of abnormal bone microarchitecture in women with anorexia nervosa. Bone. 2010;46(2):458–63. https://doi.org/10.1016/j.bone.2009.09.005.

    Article  CAS  PubMed  Google Scholar 

  57. Lawson EA, Donoho D, Miller KK, Misra M, Meenaghan E, Lydecker J, et al. Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa. J Clin Endocrinol Metab. 2009;94(12):4710–6. https://doi.org/10.1210/jc.2009-1046.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Fazeli PK, Faje AT, Cross EJ, Lee H, Rosen CJ, Bouxsein ML, et al. Serum FGF-21 levels are associated with worsened radial trabecular bone microarchitecture and decreased radial bone strength in women with anorexia nervosa. Bone. 2015;77:6–11. https://doi.org/10.1016/j.bone.2015.04.001.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Misra M, Prabhakaran R, Miller KK, Goldstein MA, Mickley D, Clauss L, et al. Prognostic indicators of changes in bone density measures in adolescent girls with anorexia nervosa-II. J Clin Endocrinol Metab. 2008;93(4):1292–7. https://doi.org/10.1210/jc.2007-2419.

    Article  CAS  PubMed  Google Scholar 

  60. Utz AL, Lawson EA, Misra M, Mickley D, Gleysteen S, Herzog DB, et al. Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa. Bone. 2008;43(1):135–9. https://doi.org/10.1016/j.bone.2008.03.007.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Lawson EA, Donoho DA, Blum JI, Meenaghan EM, Misra M, Herzog DB, et al. Decreased nocturnal oxytocin levels in anorexia nervosa are associated with low bone mineral density and fat mass. J Clin Psychiatry. 2011;72(11):1546–51. https://doi.org/10.4088/JCP.10m06617.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Wiegelmann W, Solbach HG. Effects of LH-RH on plasma levels of LH and FSH in anorexia nervosa. Horm Metab Res. 1972;4(5):404. https://doi.org/10.1055/s-0028-1097104.

    Article  CAS  PubMed  Google Scholar 

  63. Mecklenburg RS, Loriaux DL, Thompson RH, Andersen AE, Lipsett MB. Hypothalamic dysfunction in patients with anorexia nervosa. Medicine. 1974;53(2):147–59.

    Article  CAS  PubMed  Google Scholar 

  64. Travaglini P, Beck-Peccoz P, Ferrari C, Ambrosi B, Paracchi A, Severgnini A, et al. Some aspects of hypothalamic-pituitary function in patients with anorexia nervosa. Acta Endocrinol. 1976;81(2):252–62.

    Article  CAS  Google Scholar 

  65. Nillius SJ, Fries H, Wide L. Successful induction of follicular maturation and ovulation by prolonged treatment with LH-releasing hormone in women with anorexia nervosa. Am J Obstet Gynecol. 1975;122(8):921–8.

    Article  CAS  PubMed  Google Scholar 

  66. Boyar RM, Katz J, Finkelstein JW, Kapen S, Weiner H, Weitzman ED, et al. Anorexia nervosa. Immaturity of the 24-hour luteinizing hormone secretory pattern. N Engl J Med. 1974;291(17):861–5. https://doi.org/10.1056/NEJM197410242911701.

    Article  CAS  PubMed  Google Scholar 

  67. Riis BJ, Rodbro P, Christiansen C. The role of serum concentrations of sex steroids and bone turnover in the development and occurrence of postmenopausal osteoporosis. Calcif Tissue Int. 1986;38(6):318–22.

    Article  CAS  PubMed  Google Scholar 

  68. Seeman E. Estrogen, androgen, and the pathogenesis of bone fragility in women and men. Curr Osteoporos Rep. 2004;2(3):90–6.

    Article  PubMed  Google Scholar 

  69. Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R, Khosla S. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest. 2000;106(12):1553–60. https://doi.org/10.1172/JCI10942.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Finkelstein JS, Lee H, Leder BZ, Burnett-Bowie SA, Goldstein DW, Hahn CW, et al. Gonadal steroid-dependent effects on bone turnover and bone mineral density in men. J Clin Invest. 2016;126(3):1114–25. https://doi.org/10.1172/JCI84137.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Klibanski A, Biller BM, Schoenfeld DA, Herzog DB, Saxe VC. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab. 1995;80(3):898–904.

    CAS  PubMed  Google Scholar 

  72. Golden NH, Lanzkowsky L, Schebendach J, Palestro CJ, Jacobson MS, Shenker IR. The effect of estrogen-progestin treatment on bone mineral density in anorexia nervosa. J Pediatr Adolesc Gynecol. 2002;15(3):135–43.

    Article  PubMed  Google Scholar 

  73. Grinspoon S, Thomas L, Miller K, Herzog D, Klibanski A. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab. 2002;87(6):2883–91.

    Article  CAS  PubMed  Google Scholar 

  74. Misra M, Katzman D, Miller KK, Mendes N, Snelgrove D, Russell M, et al. Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. J Bone Miner Res Off J Am Soc Bone Miner Res. 2011;26(10):2430–8. https://doi.org/10.1002/jbmr.447.

    Article  CAS  Google Scholar 

  75. Counts DR, Gwirtsman H, Carlsson LM, Lesem M, Cutler GB Jr. The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. J Clin Endocrinol Metab. 1992;75(3):762–7.

    CAS  PubMed  Google Scholar 

  76. Weissberger AJ, Ho KK, Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab. 1991;72(2):374–81. https://doi.org/10.1210/jcem-72-2-374.

    Article  CAS  PubMed  Google Scholar 

  77. Kam GY, Leung KC, Baxter RC, Ho KK. Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and the acid-labile subunit of the IGF ternary complex. J Clin Endocrinol Metab. 2000;85(5):1918–22. https://doi.org/10.1210/jcem.85.5.6527.

    Article  CAS  PubMed  Google Scholar 

  78. Saggese G, Bertelloni S, Baroncelli GI, Di Nero G. Serum levels of carboxyterminal propeptide of type I procollagen in healthy children from 1st year of life to adulthood and in metabolic bone diseases. Eur J Pediatr. 1992;151(10):764–8.

    Article  CAS  PubMed  Google Scholar 

  79. Heer M, Mika C, Grzella I, Heussen N, Herpertz-Dahlmann B. Bone turnover during inpatient nutritional therapy and outpatient follow-up in patients with anorexia nervosa compared with that in healthy control subjects. Am J Clin Nutr. 2004;80(3):774–81. https://doi.org/10.1093/ajcn/80.3.774.

    Article  CAS  PubMed  Google Scholar 

  80. Hotta M, Fukuda I, Sato K, Hizuka N, Shibasaki T, Takano K. The relationship between bone turnover and body weight, serum insulin-like growth factor (IGF) I, and serum IGF-binding protein levels in patients with anorexia nervosa. J Clin Endocrinol Metab. 2000;85(1):200–6.

    CAS  PubMed  Google Scholar 

  81. Weinbrenner T, Zittermann A, Gouni-Berthold I, Stehle P, Berthold HK. Body mass index and disease duration are predictors of disturbed bone turnover in anorexia nervosa. A case-control study. Eur J Clin Nutr. 2003;57(10):1262–7. https://doi.org/10.1038/sj.ejcn.1601683.

    Article  CAS  PubMed  Google Scholar 

  82. Bolton JG, Patel S, Lacey JH, White S. A prospective study of changes in bone turnover and bone density associated with regaining weight in women with anorexia nervosa. Osteoporos Int. 2005;16(12):1955–62. https://doi.org/10.1007/s00198-005-1972-7.

    Article  PubMed  Google Scholar 

  83. Viapiana O, Gatti D, Dalle Grave R, Todesco T, Rossini M, Braga V, et al. Marked increases in bone mineral density and biochemical markers of bone turnover in patients with anorexia nervosa gaining weight. Bone. 2007;40(4):1073–7. https://doi.org/10.1016/j.bone.2006.11.015.

    Article  CAS  PubMed  Google Scholar 

  84. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat Med. 1996;2(10):1132–6.

    Article  CAS  PubMed  Google Scholar 

  85. Miller KK, Meenaghan E, Lawson EA, Misra M, Gleysteen S, Schoenfeld D, et al. Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab. 2011;96(7):2081–8. https://doi.org/10.1210/jc.2011-0380.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Golden NH, Iglesias EA, Jacobson MS, Carey D, Meyer W, Schebendach J, et al. Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2005;90(6):3179–85. https://doi.org/10.1210/jc.2004-1659.

    Article  CAS  PubMed  Google Scholar 

  87. Seeman E. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis. Osteoporos Int. 2003;14(Suppl 3):S2–8. https://doi.org/10.1007/s00198-002-1340-9.

    Article  PubMed  Google Scholar 

  88. van Binsbergen CJ, Coelingh Bennink HJ, Odink J, Haspels AA, Koppeschaar HP. A comparative and longitudinal study on endocrine changes related to ovarian function in patients with anorexia nervosa. J Clin Endocrinol Metab. 1990;71(3):705–11.

    Article  PubMed  Google Scholar 

  89. Gahete MD, Cordoba-Chacon J, Luque RM, Kineman RD. The rise in growth hormone during starvation does not serve to maintain glucose levels or lean mass but is required for appropriate adipose tissue response in female mice. Endocrinology. 2013;154(1):263–9. https://doi.org/10.1210/en.2012-1849.

    Article  CAS  PubMed  Google Scholar 

  90. Zhao TJ, Liang G, Li RL, Xie X, Sleeman MW, Murphy AJ, et al. Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. Proc Natl Acad Sci U S A. 2010;107(16):7467–72. https://doi.org/10.1073/pnas.1002271107.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Garfinkel PE, Brown GM, Stancer HC, Moldofsky H. Hypothalamic-pituitary function in anorexia nervosa. Arch Gen Psychiatry. 1975;32(6):739–44.

    Article  CAS  PubMed  Google Scholar 

  92. Scacchi M, Pincelli AI, Caumo A, Tomasi P, Delitala G, Baldi G, et al. Spontaneous nocturnal growth hormone secretion in anorexia nervosa. J Clin Endocrinol Metab. 1997;82(10):3225–9.

    Article  CAS  PubMed  Google Scholar 

  93. Stoving RK, Veldhuis JD, Flyvbjerg A, Vinten J, Hangaard J, Koldkjaer OG, et al. Jointly amplified basal and pulsatile growth hormone (GH) secretion and increased process irregularity in women with anorexia nervosa: indirect evidence for disruption of feedback regulation within the GH-insulin-like growth factor I axis. J Clin Endocrinol Metab. 1999;84(6):2056–63.

    CAS  PubMed  Google Scholar 

  94. Misra M, Miller KK, Bjornson J, Hackman A, Aggarwal A, Chung J, et al. Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab. 2003;88(12):5615–23.

    Article  CAS  PubMed  Google Scholar 

  95. Grinspoon SK, Baum HB, Peterson S, Klibanski A. Effects of rhIGF-I administration on bone turnover during short-term fasting. J Clin Invest. 1995;96(2):900–6. https://doi.org/10.1172/JCI118137.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Fazeli PK, Lawson EA, Prabhakaran R, Miller KK, Donoho DA, Clemmons DR, et al. Effects of recombinant human growth hormone in anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab. 2010;95(11):4889–97. https://doi.org/10.1210/jc.2010-0493.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Grinspoon S, Baum H, Lee K, Anderson E, Herzog D, Klibanski A. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab. 1996;81(11):3864–70. https://doi.org/10.1210/jcem.81.11.8923830.

    Article  CAS  PubMed  Google Scholar 

  98. Misra M, McGrane J, Miller KK, Goldstein MA, Ebrahimi S, Weigel T, et al. Effects of rhIGF-1 administration on surrogate markers of bone turnover in adolescents with anorexia nervosa. Bone. 2009;45(3):493–8. https://doi.org/10.1016/j.bone.2009.06.002.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 2007;5(6):426–37. https://doi.org/10.1016/j.cmet.2007.05.002.

    Article  CAS  PubMed  Google Scholar 

  100. Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, Parameswara V, et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 2007;5(6):415–25. https://doi.org/10.1016/j.cmet.2007.05.003.

    Article  CAS  PubMed  Google Scholar 

  101. Fazeli PK, Lun M, Kim SM, Bredella MA, Wright S, Zhang Y, et al. FGF21 and the late adaptive response to starvation in humans. J Clin Invest. 2015;125(12):4601–11. https://doi.org/10.1172/JCI83349.

    Article  PubMed  PubMed Central  Google Scholar 

  102. Inagaki T, Lin VY, Goetz R, Mohammadi M, Mangelsdorf DJ, Kliewer SA. Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab. 2008;8(1):77–83. https://doi.org/10.1016/j.cmet.2008.05.006.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Fazeli PK, Misra M, Goldstein M, Miller KK, Klibanski A. Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa. J Clin Endocrinol Metab. 2010;95(1):369–74. https://doi.org/10.1210/jc.2009-1730.

    Article  CAS  PubMed  Google Scholar 

  104. Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, et al. FGF-21 as a novel metabolic regulator. J Clin Invest. 2005;115(6):1627–35. https://doi.org/10.1172/JCI23606.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Wei W, Dutchak PA, Wang X, Ding X, Wang X, Bookout AL, et al. Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor gamma. Proc Natl Acad Sci U S A. 2012;109(8):3143–8. https://doi.org/10.1073/pnas.1200797109.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Morris HA, Need AG, O'Loughlin PD, Horowitz M, Bridges A, Nordin BE. Malabsorption of calcium in corticosteroid-induced osteoporosis. Calcif Tissue Int. 1990;46(5):305–8.

    Article  CAS  PubMed  Google Scholar 

  107. Hansen JW, Gordan GS, Prussin SG. Direct measurement of osteolysis in man. J Clin Invest. 1973;52(2):304–15. https://doi.org/10.1172/JCI107186.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  108. Canalis E. Clinical review 83: mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab. 1996;81(10):3441–7.

    CAS  PubMed  Google Scholar 

  109. Rauch A, Seitz S, Baschant U, Schilling AF, Illing A, Stride B, et al. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab. 2010;11(6):517–31. https://doi.org/10.1016/j.cmet.2010.05.005.

    Article  CAS  PubMed  Google Scholar 

  110. Padmanabhan V, Keech C, Convey EM. Cortisol inhibits and adrenocorticotropin has no effect on luteinizing hormone-releasing hormone-induced release of luteinizing hormone from bovine pituitary cells in vitro. Endocrinology. 1983;112(5):1782–7.

    Article  CAS  PubMed  Google Scholar 

  111. Walsh BT, Katz JL, Levin J, Kream J, Fukushima DK, Hellman LD, et al. Adrenal activity in anorexia nervosa. Psychosom Med. 1978;40(6):499–506.

    Article  CAS  PubMed  Google Scholar 

  112. Boyar RM, Hellman LD, Roffwarg H, Katz J, Zumoff B, O'Connor J, et al. Cortisol secretion and metabolism in anorexia nervosa. N Engl J Med. 1977;296(4):190–3. https://doi.org/10.1056/NEJM197701272960403.

    Article  CAS  PubMed  Google Scholar 

  113. Misra M, Miller KK, Almazan C, Ramaswamy K, Lapcharoensap W, Worley M, et al. Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab. 2004;89(10):4972–80. https://doi.org/10.1210/jc.2004-0723.

    Article  CAS  PubMed  Google Scholar 

  114. Zumoff B, Walsh BT, Katz JL, Levin J, Rosenfeld RS, Kream J, et al. Subnormal plasma dehydroisoandrosterone to cortisol ratio in anorexia nervosa: a second hormonal parameter of ontogenic regression. J Clin Endocrinol Metab. 1983;56(4):668–72.

    Article  CAS  PubMed  Google Scholar 

  115. Winterer J, Gwirtsman HE, George DT, Kaye WH, Loriaux DL, Cutler GB Jr. Adrenocorticotropin-stimulated adrenal androgen secretion in anorexia nervosa: impaired secretion at low weight with normalization after long-term weight recovery. J Clin Endocrinol Metab. 1985;61(4):693–7. https://doi.org/10.1210/jcem-61-4-693.

    Article  CAS  PubMed  Google Scholar 

  116. Divasta AD, Feldman HA, Giancaterino C, Rosen CJ, Leboff MS, Gordon CM. The effect of gonadal and adrenal steroid therapy on skeletal health in adolescents and young women with anorexia nervosa. Metab Clin Exp. 2012;61(7):1010–20. https://doi.org/10.1016/j.metabol.2011.11.016.

    Article  CAS  PubMed  Google Scholar 

  117. DiVasta AD, Feldman HA, Beck TJ, LeBoff MS, Gordon CM. Does hormone replacement normalize bone geometry in adolescents with anorexia nervosa? J Bone Miner Res Off J Am Soc Bone Miner Res. 2014;29(1):151–7. https://doi.org/10.1002/jbmr.2005.

    Article  CAS  Google Scholar 

  118. Gordon CM, Grace E, Emans SJ, Feldman HA, Goodman E, Becker KA, et al. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. J Clin Endocrinol Metab. 2002;87(11):4935–41.

    Article  CAS  PubMed  Google Scholar 

  119. Bloch M, Ish-Shalom S, Greenman Y, Klein E, Latzer Y. Dehydroepiandrosterone treatment effects on weight, bone density, bone metabolism and mood in women suffering from anorexia nervosa-a pilot study. Psychiatry Res. 2012;200(2–3):544–9. https://doi.org/10.1016/j.psychres.2012.07.012.

    Article  CAS  PubMed  Google Scholar 

  120. Halmi KA, Sunday S, Puglisi A, Marchi P. Hunger and satiety in anorexia and bulimia nervosa. Ann N Y Acad Sci. 1989;575:431–44 discussion 44-5.

    Article  CAS  PubMed  Google Scholar 

  121. Wong IP, Driessler F, Khor EC, Shi YC, Hormer B, Nguyen AD, et al. Peptide YY regulates bone remodeling in mice: a link between gut and skeletal biology. PLoS One. 2012;7(7):e40038. https://doi.org/10.1371/journal.pone.0040038.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  122. Otto B, Cuntz U, Fruehauf E, Wawarta R, Folwaczny C, Riepl RL, et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol. 2001;145(5):669–73.

    Article  CAS  PubMed  Google Scholar 

  123. Fukushima N, Hanada R, Teranishi H, Fukue Y, Tachibana T, Ishikawa H, et al. Ghrelin directly regulates bone formation. J Bone Miner Res Off J Am Soc Bone Miner Res. 2005;20(5):790–8. https://doi.org/10.1359/JBMR.041237.

    Article  CAS  Google Scholar 

  124. Misra M, Miller KK, Stewart V, Hunter E, Kuo K, Herzog DB, et al. Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents. J Clin Endocrinol Metab. 2005;90(9):5082–7. https://doi.org/10.1210/jc.2005-0512.

    Article  CAS  PubMed  Google Scholar 

  125. Hotta M, Ohwada R, Katakami H, Shibasaki T, Hizuka N, Takano K. Plasma levels of intact and degraded ghrelin and their responses to glucose infusion in anorexia nervosa. J Clin Endocrinol Metab. 2004;89(11):5707–12. https://doi.org/10.1210/jc.2004-0353.

    Article  CAS  PubMed  Google Scholar 

  126. Fazeli PK, Lawson EA, Faje AT, Eddy KT, Lee H, Fiedorek FT, et al. Treatment with a ghrelin agonist in outpatient women with anorexia nervosa: a randomized clinical trial. J Clin Psychiatry. 2018; in press.

  127. Fazeli PK, Klibanski A. The paradox of marrow adipose tissue in anorexia nervosa. Bone. 2019;118:47–52. https://doi.org/10.1016/j.bone.2018.02.013.

    Article  CAS  PubMed  Google Scholar 

  128. Tamma R, Colaianni G, Zhu LL, DiBenedetto A, Greco G, Montemurro G, et al. Oxytocin is an anabolic bone hormone. Proc Natl Acad Sci U S A. 2009;106(17):7149–54. https://doi.org/10.1073/pnas.0901890106.

    Article  PubMed  PubMed Central  Google Scholar 

  129. Elabd C, Basillais A, Beaupied H, Breuil V, Wagner N, Scheideler M, et al. Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis. Stem Cells. 2008;26(9):2399–407. https://doi.org/10.1634/stemcells.2008-0127.

    Article  CAS  PubMed  Google Scholar 

  130. Abdallah BM, Jensen CH, Gutierrez G, Leslie RG, Jensen TG, Kassem M. Regulation of human skeletal stem cells differentiation by Dlk1/Pref-1. J Bone Miner Res Off J Am Soc Bone Miner Res. 2004;19(5):841–52. https://doi.org/10.1359/JBMR.040118.

    Article  CAS  Google Scholar 

  131. McClung MR, Grauer A, Boonen S, Bolognese MA, Brown JP, Diez-Perez A, et al. Romosozumab in postmenopausal women with low bone mineral density. N Engl J Med. 2014;370(5):412–20. https://doi.org/10.1056/NEJMoa1305224.

    Article  CAS  PubMed  Google Scholar 

  132. Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S, et al. Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med. 2016;375(16):1532–43. https://doi.org/10.1056/NEJMoa1607948.

    Article  CAS  PubMed  Google Scholar 

  133. Maimoun L, Guillaume S, Lefebvre P, Philibert P, Bertet H, Picot MC, et al. Role of sclerostin and Dickkopf-1 in the dramatic alteration in bone mass acquisition in adolescents and young women with recent anorexia nervosa. J Clin Endocrinol Metab. 2014:jc20132565. https://doi.org/10.1210/jc.2013-2565.

  134. Fazeli PK, Wang IS, Miller KK, Herzog DB, Misra M, Lee H, et al. Teriparatide increases bone formation and bone mineral density in adult women with anorexia nervosa. J Clin Endocrinol Metab. 2014:jc20134105. https://doi.org/10.1210/jc.2013-4105.

  135. Faje AT, Fazeli PK, Katzman DK, Miller KK, Breggia A, Rosen CJ, et al. Sclerostin levels and bone turnover markers in adolescents with anorexia nervosa and healthy adolescent girls. Bone. 2012;51(3):474–9. https://doi.org/10.1016/j.bone.2012.06.006.

    Article  PubMed  PubMed Central  Google Scholar 

  136. Bachrach LK, Katzman DK, Litt IF, Guido D, Marcus R. Recovery from osteopenia in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab. 1991;72(3):602–6. https://doi.org/10.1210/jcem-72-3-602.

    Article  CAS  PubMed  Google Scholar 

  137. Vahle JL, Sato M, Long GG, Young JK, Francis PC, Engelhardt JA, et al. Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety. Toxicol Pathol. 2002;30(3):312–21. https://doi.org/10.1080/01926230252929882.

    Article  CAS  PubMed  Google Scholar 

  138. Schilcher J, Koeppen V, Aspenberg P, Michaelsson K. Risk of atypical femoral fracture during and after bisphosphonate use. N Engl J Med. 2014;371(10):974–6. https://doi.org/10.1056/NEJMc1403799.

    Article  PubMed  Google Scholar 

  139. Patlas N, Golomb G, Yaffe P, Pinto T, Breuer E, Ornoy A. Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology. 1999;60(2):68–73. https://doi.org/10.1002/(SICI)1096-9926(199908)60:2<68::AID-TERA10>3.0.CO;2-H.

    Article  CAS  PubMed  Google Scholar 

  140. Lin JH. Bisphosphonates: a review of their pharmacokinetic properties. Bone. 1996;18(2):75–85.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This project was supported by NIH grant R03 DK106410. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Funding

This project was supported by NIH grant R03 DK106410.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pouneh K. Fazeli.

Ethics declarations

Conflict of Interest

The author declares that she has no conflict of interest.

Ethical Approval

Not applicable.

Informed Consent

Not applicable.

Disclosures

No disclosures.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fazeli, P.K. Low Bone Mineral Density in Anorexia Nervosa: Treatments and Challenges. Clinic Rev Bone Miner Metab 17, 65–76 (2019). https://doi.org/10.1007/s12018-019-09260-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12018-019-09260-4

Keywords

Navigation